At INB9, governments must address outstanding issues to safeguard equitable access to medical products

MSF statement at INB7 on the proposal for negotiating next of Pandemic Accord

MSF statement at the 5th Intergovernmental Negotiating Body (INB) on WHO Pandemic Accord

Regarding the text of the declaration for the upcoming UN High-Level Meeting (HLM) on HIV/AIDS, MSF released this statement urging all countries to recognise and retain the full rights and use of international public health safeguards ...

MSF Statement on Agenda Item 13.4 concerning the draft resolution, “Strengthening local production of medicines and other health technologies to improve access.”

In their statement at a recent virtual event titled "COVID-19 and Vaccine Equity: What Can the WTO Contribute?" held on 14 April 2021, the EU Commission continued to defend a position that leaves a handful of pharmaceutical companies ...

Médecins Sans Frontières (MSF) welcomes the SCP to continue the discussion of the agenda item Patents and Health. It is a critical time for WIPO members to closely examine the implication of patent law on access to medicines in the ...

Ahead of a transition period that allows least-developed countries (LDCs) to avoid introducing some intellectual property (IP) rules expiring next year, LDC members of the World Trade Organization (WTO), led by Chad, have requested an ...

MSF urges South Africa to stand strong in defiance of aggressive pharma moves to delay change

Ahead of a transition period that allows least-developed countries (LDC) to avoid introducing some intellectual property rules expiring this month, LDC members of the World Trade Organization (WTO) requested an extension that would ...